INGN
What one share of Inogen holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox® product for airway clearance treatment.
Inogen’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $13.05 |
|---|---|
| Profit | −$0.91 |
| Capex (buildings and equipment) | $0.09 |
| Free cash flow | −$0.18 |
| Cash and investments | $3.27 |
| Book value | $6.54 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $9.61 | $0.97 | $0.08 | $1.39 | — | $8.93 |
| 2017 | $11.39 | $0.96 | $0.13 | $2.63 | — | $10.82 |
| 2018 | $15.91 | $2.30 | $0.36 | $2.31 | — | $14.25 |
| 2019 | $16.27 | $0.94 | $0.14 | $1.68 | — | $15.64 |
| 2020 | $14.03 | −$0.27 | $0.20 | $1.48 | — | $15.80 |
| 2021 | $15.92 | −$0.28 | $0.24 | $0.81 | — | $16.29 |
| 2022 | $16.51 | −$3.67 | $0.15 | −$1.79 | — | $12.96 |
| 2023 | $13.62 | −$4.42 | $0.23 | −$0.36 | — | $8.78 |
| 2024 | $14.19 | −$1.52 | $0.14 | $0.11 | — | $7.27 |
| 2025 | $13.11 | −$0.86 | $0.09 | −$0.52 | — | $7.06 |